Abstract. We report a photonic approach for selective inactivation of viruses with a near-infrared subpicosecond laser. We demonstrate that this method can selectively inactivate viral particles ranging from nonpathogenic viruses such as the M13 bacteriophage and the tobacco mosaic virus to pathogenic viruses such as the human papillomavirus and the human immunodeficiency virus ͑HIV͒. At the same time, sensitive materials such as human Jurkat T cells, human red blood cells, and mouse dendritic cells remain unharmed. The laser technology targets the global mechanical properties of the viral protein shell, making it relatively insensitive to the local genetic mutation in the target viruses. As a result, the approach can inactivate both the wild and mutated strains of viruses. This intriguing advantage is particularly important in the treatment of diseases involving rapidly mutating viral species such as HIV. Our photonic approach could be used for the disinfection of viral pathogens in blood products and for the treatment of blood-borne viral diseases in the clinic.
Introduction
Biochemical and pharmaceutical methods currently used for the inactivation of viral particles, although quite successful, encounter problems of drug resistance in the target virus. In addition, they also have clinical side effects. The ultraviolet ͑UV͒ disinfection method 1,2 is effective, however, UV lamps target both the nuclei acids and proteins, as a result they damage not only the viral particles but also the mammalian cells; in other words, it has no selectivity. In addition, UV irradiation raises concerns of mutation and has shadowing effects due to its relatively small penetration depth. The microwave absorption technique is not effective because most of the energy is transferred to the water and not to the target viral particle. Recently, a photochemical technique 3 was developed to disinfect blood supplies. However, potential risks and side effects have hindered its applications. A new method that circumvents these problems is therefore desirable.
In this paper, we report a photonic approach for selective inactivation of viruses with a near-IR subpicosecond laser. Our method with a near-IR ultrafast laser system, in contrast to the UV lamp technology, targets only the weak links on the protein shells of viral particles. By tuning to the appropriate laser power density, we demonstrate that it is feasible to damage the protein shells of viral particles leading to the inactivation of viral particles without harming the mammalian cells. Specifically, we demonstrate that this method can selectively inactivate viral particles ranging from nonpathogenic viruses such as the M13 bacteriophage and the tobacco mosaic virus ͑TMV͒ to pathogenic viruses such as the human papillomavirus ͑HPV͒ and the human immunodeficiency virus ͑HIV͒, while sensitive materials such as human Jurkat T cells, human red blood cells, and mouse dendritic cells remain unharmed. In contrast to the UV lamp irradiation method, our photonic approach with a near-IR subpicosecond laser system not only provides selectivity but also minimizes shadowing effects ͑be-cause penetration depth is much larger for the IR wavelength than for the UV wavelength͒.
Experimental Method, Samples, and Assays

Laser and Experimental Setup
The excitation source used in the inactivation of viruses was a compact, ultrashort pulsed fiber laser ͑with seed and amplifier, from Raydiance Inc.͒. As shown in Fig. 1 , the ultrashort pulsed fiber laser, which has a wavelength of 1.55 m, was operated at a repetition rate of 500 kHz and 5 J per laser pulse. The output of the second-harmonic generation ͑SHG͒ system of the fiber laser was used in the laser-irradiation experiments. It has a wavelength of 776 nm, about 1.4 J per laser pulse, a pulse width of full width at half maximum of about 600 fs, and a spectral width of about 70 cm −1 . Water, which usually coexists with biological microorganisms, absorbs radiation at 1.55 m very severely, but is rather transparent in the near-IR and visible ranges. This is why the SHG beam was used. In all of our experiments, a single laser beam was used for the inactivation of viruses. A different laser power density was achieved by varying the average laser power and the size of the laser beam with an achromatic lens of long focal length. A magnetic stirrer ͑Corning Model: PC-420͒ was used to stir the viral sample in its buffer solution so as to facilitate the interaction of the laser with the viral particles. The duration of the laser irradiation was 2 h in all of our experiments. All the laser-irradiation experiments were carried out at T =25°C. All the data are expressed in the form of ͑meanϮ standard deviation͒.
Samples and Assays
For M13 bacteriophage
The VCSM13 Interference-Resistant Helper phage was purchased from Stratagene. To determine the infectivity of the helper phages from different batches, we diluted the phage to 10 3 plaque forming unit ͑pfu͒ in 50 l of phosphate-buffered saline ͑PBS͒ and added the diluted phage to 1 ml of TG-1 E. coli growing at an OD 600 ͑optical density at 600 nm͒ of 0.4. The E. coli solution was then added into 3 ml of agarose top ͑10 g Bacto-Tryptone, 5 g yeast extract, 5 g NaCl, 1 g MgCl 2 ·6H 2 O, 7 g agarose in 1 l of water͒. After brief vortex, the mixture was poured evenly onto TYE plates ͑15 g BactoAgar, 8 g NaCl, 10 g Tryptone, 5 g yeast extract in 1 l of water͒ and cooled at room temperature until solidification. The plates were incubated at 37°C overnight and plaques were counted on the next day. Plaque formation assay was performed in triplicate for each batch of phage. On another assay, we diluted the phage in serial amount from 10 to 10 3 pfu in 50 l of PBS and added into 1 ml of TG-1 culture followed by plating as already described.
After overnight culture of TG-1 E. coli with helper phage on the agars plate, the discrete plaques was labeled and counted.
For HPV
HPV16 SEAP ͑secreated alkaline phosphatase͒ assay was performed as described earlier. 4 Neutralization buffer was prepared by mixing DMEM ͑Dulbecco modified Eagle medium͒ without phenol red, 10% heat-inactivated FBS ͑fetal bovine serum͒, 1% nonessential amino acids, and 1% penicillin-streptomycin. The 293TT cells were plated 3 to 4 h before treatment in 96-well tissueculture-treated flat-bottom plates at 30,000 cells/well in 100 l neutralization buffer. Optiprep-purified HPV16 PV having SEAP as a reporter was diluted 1000-fold. At these dilutions, target cells typically generated enough SEAP for an output reading. The 100-l pseudovirus treated with the laser was transferred onto the preplated cells and incubated for 68 to 72 h. At the end of the incubation, 40 l of supernatant was harvested and clarified at 1500ϫ g for 5 min. The SEAP content in the clarified supernatant was determined using p-nitrophenyl phosphate tablets ͑Sigma, St. Louis, Missouri͒ dissolved in diethanolamine, and absorbance was measured at 405 nm.
For HIV
HIV stocks ͓NL4-3, provided by the National Institutes of Health ͑NIH͔͒ were diluted to 1 ϫ 10 5 cpm/ ml in DMEM ͑with no phenol red͒ for the laser-irradiation experiments.
U373-MAGI-CXCR4 CEM cells ͑NIH AIDS Research & Reference Reagent Program͒ were seeded at 6 ϫ 10 4 cells/ well in 24-well plates. To assay the infectivity of HIV, these cells were infected with samples, either laser-irradiated or not irradiated ͑control͒, at the indicated viral concentrations. Following a 48-h incubation, cells were fixed with a 1% paraformaldeyhde, 0.2% gluteraldehyde solution prepared in PBS. Fixed cells were washed twice with PBS and stained with a solution containing 0.4 mM potassium ferrocyanide, 2.0 mM MgCl 2 , and 0.4 mg/ ml X-gal. Cells positive for ␤-galactosidase activity were counted manually ͑sum of 10 fields, duplicate samples͒.
For TMV
Tobacco mosaic viruses from the infected tobacco leaves were extracted and used as the source of virus in our experiments. The atomic force microscope ͑AFM͒ images showing the release of single-strand RNA from TMV were used as an indication of the inactivation.
Imaging Viruses with Atomic Force Microscope
Biomolecules such as protein, DNA and RNA can be easily captured on the APTES ͑Aminopropyltriethoxysilane͒-modified surface using glutaradehyde. The laser-irradiated viral particles were immobilized on the APTES mica and imaged [5] [6] [7] [8] under the AFM.
APTES mica preparation
Fresh cleaved mica was placed in a desiccator with 30 l APTES ͑99%, Sigma-Aldrich, St. Louis, Missouri͒ and 10 l N , N-diisopropylethylamine ͑99%, distilled, Sigma-Aldrich͒ in the bottom. The desiccator was then purged with argon for 3 min, and the mica was allowed to remain in the APTES vapor for 1 h to achieve good modification.
Sample immobilization
One hundred microliters of 2 M glutaradehyde ͑grade I, Sigma-Aldrich͒ was deposited onto the APTES mica surface for 10 min, and the surface was then washed gently with distilled water. After that, 200 l of virus samples with concentration range from 1 ϫ 10 6 to 1 ϫ 10 8 particles per milliliter was pipetted onto the glutaradehyde-treated mica surface and allowed to incubate for 40 to 80 min. The mica surface, now containing the immobilized sample, was then gently rinsed with distilled water and dried with nitrogen.
Imaging
Imaging was carried out with a PicoPlus 2500+ AFM ͓Mo-lecular Imaging; now 5500 AFM ͑N9410S͒ from Agilent͔ equipped with a Si 3 N 4 cantilever ͑AppNano SPM͒ with a spring constant range from 25 to 75 N / m and the resonance frequency around 300 kHz 3 Experimental Results Figure 2͑a͒ shows the number of plaques of two typical assays for a sample with 1 ϫ 10 3 pfu of M13 bacteriophages without the laser irradiation ͑control͒ and with laser irradiation. The laser power density used was 100Ϯ 10 MW/ cm 2 . The number of plaques was determined to be 990Ϯ 49 counts for the Tsen et al.: Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laser control. In contrast, the number of plaques after laser irradiation was 3 Ϯ 2 counts. The important feature is that there is a minimal number of plaques for the laser irradiated sample as compared with the control, indicative of the very efficient inactivation of M13 bacteriophages by the ultrashort pulsed ͑USP͒ laser irradiation. A viral load reduction of about 10 3 was observed.
Inactivation of M13 Bacteriophages
Inactivation of TMV
The assay of TMV was performed by counting the singlestranded RNA released in the laser-irradiated sample with AFM, i.e., one count of single-stranded RNA observed in the AFM image corresponds to inactivation of one TMV in the laser irradiated sample. Figure 2͑b͒ shows the number of TMV particles in the control and laser-irradiated samples, respectively. The control had 105Ϯ 6 TMV particles, whereas the laser-irradiated sample had 44Ϯ 3. The laser power density employed was 900Ϯ 90 MW/ cm 2 . USP laser irradiation reduced the viral load by a factor of about 55%.
Inactivation of HPV
The inactivation of HPV was determined from SEAP assays. Figure 2͑c͒ shows the number of HPV particles for the control and laser-irradiated samples, respectively. The control had 9980Ϯ 400 HPV particles and the laser-irradiated sample had 2 Ϯ 1. The laser power density used was 1.0Ϯ 0.1 GW/ cm 2 .
A viral load reduction of about 10 4 was recorded.
Inactivation of HIV
The inactivation of HIV was assayed by monitoring the infectivity of U373-MAGI-CXCR4 CEM cells. Figure 2͑d͒ shows the number of infected cells-an indicator of the number of HIV-for the control and laser-irradiated HIV samples, respectively. The laser power density used in the experiments was 1.1Ϯ 0.1 GW/ cm 2 . The control sample revealed infection of 60Ϯ 3 CD4 + T cells; whereas the laser-irradiated sample shows 12Ϯ 1. A reduction of viral infectivity of about 80% was observed.
Images from Atomic Force Microscopy
M13 bacteriophage is a rod-shaped virus with a diameter of about 6 nm and a length of about 850 nm. Its capsid is made up of proteins assembled in helical shape and wrapped around a single-stranded DNA. Figures 3͑a͒ and 3͑b͒ show AFM images of M13 phage without and with laser irradiation, respectively. The laser power density used was 200Ϯ 20 MW/ cm 2 . The wormlike features in Fig. 3͑a͒ reveal the presence of M13 bacteriophages in the control. Nearly all the wormlike features disappear and are replaced by mucuslike structures after laser irradiation ͓Fig. 3͑b͔͒, indicative that the laser irradiation affects the global structure of the viral capsid coat. TMV is a rod-shaped virus whose length can vary depending on the method of extraction. On average, it has a length of about 300 nm, a diameter of about 18 nm, and contains a single-stranded RNA. The rectangular white structures correspond to AFM images of TMV in the control ͓Fig. 3͑c͔͒. The very narrow wormlike features, which show up only in the laser-irradiated sample ͓Fig. 3͑d͔͒, represent single-stranded RNAs released from the TMV, presumably as a result of huge vibrations of the TMV protein shell coherently excited by the laser, as discussed in the following. The laser power density used was 1.0Ϯ 0.1 GW/ cm 2 .
Therefore, AFM images for M13 bacteriophages and TMV have clearly demonstrated that USP laser irradiation can affect the structural integrity of the capsid of a virus.
Imaging the laser-irradiated samples for both HPV and HIV with the AFM is being planned. These experiments, which can provide valuable information about the effects of laser irradiation, are challenging because of the highly infectious properties of the viruses.
Inactivation of Both the Wild and Genetically Modified M13 Bacteriophages
We have also carried out wild-type M13 bacteriophages in addition to the interference-resistant helper phages already shown. These results indicate that the threshold laser power intensities for inactivation of M13 bacteriophage and M13 interference-resistant helper phage are the same ͑within the experimental uncertainty͒. These experimental results suggest that our method can overcome limitations with current therapeutics that arise due to mutations. We believe that this novel property of our method is due to the fact that the excited coherent acoustic vibrations induced in the capsids of M13 phages are usually of long wavelength. As a result, they are relatively insensitive to the minor local changes such as those due to mutations. Figure 4 shows the number of plaques as a function of the laser exposure time for a M13 bacteriophage sample. The laser power density used was 100Ϯ 10 MW/ cm 2 . The inactivation is approximately exponential with a time constant of about 0.2 h. The number of viral particles was reduced to less than about 10% after 0.5 h of exposure to laser irradiation, and to less than about 0.5% after 1 h of laser exposure time.
Efficiency of the Method
We have found that the efficiency of inactivation depends on how efficiently the viral particle was placed within the effective volume of the near-IR subpicosecond fiber laser within the vial. More efficient magnetic stirring gives rise to more efficient inactivation.
Selective Inactivation
We now evaluate the effects of the near-IR subpicosecond fiber laser light on other microorganisms besides viruses. Table 1 summarizes the threshold laser power density for inactivation of a variety of microorganisms, including human red blood cells, human Jurkat cells, and mouse dendritic cells. Much higher laser power intensities are necessary to inactivate these cells. These results indicate that there exists a window in laser power density ͑or equivalently, laser intensity because the same laser was used for the experiments͒, which was bounded approximately by 1 GW/ cm 2 and 10 GW/ cm 2 , that enables us to inactivate unwanted microorganisms such as viruses, while leaving useful materials like mammalian cells unharmed. It is therefore plausible that the near-IR subpicosecond fiber laser, if appropriately manipulated, can be used to selectively kill blood-borne pathogens with minimal damage to sensitive materials. It is this selectivity of our method that distinguishes our approach from currently available methods. Our photonic approach has great potential to be used for the disinfection of viral pathogens in blood products and for the treatment of blood-borne viral diseases performed as a dialysis process in the clinic with minimal side effects.
Dependence of Inactivation on the Excitation
Laser Power Density Figure 5 shows the dependence of inactivation of a M13 bacteriophage sample on the power density of excitation laser. The laser exposure time was kept at 10 h. When the power density was lower than about 40 MW/ cm 2 , no inactivation was observed within the experimental uncertainty; however, as the power density was increased to 60 MW/ cm 2 and higher, inactivation was seen to occur. The abrupt separation of laser power density around 60 MW/ cm 2 for the inactivation of M13 bacteriophage was consistent with the argument that damage on the capsid was the cause of inactivation.
Discussion
One can obtain a very valuable hint about the likely mechanism͑s͒ for the inactivation of viruses with an USP laser from the AFM images presented here for M13 bacteriophages and TMV. The AFM images from Figs. 3͑a͒-3͑d͒ strongly suggest that the probable mechanism for inactivation of viruses by the near-IR subpicosecond fiber laser is concomitant with laserinduced damage of the capsid.
To our knowledge, there are three possible mechanisms in which an USP laser can produce vibrational motions on either a solid state system or a biological molecular system. One possible physical mechanism of inactivation of a virus is direct excitation of vibrational Raman-active modes on the capsid of a virus by a near-IR subpicosecond fiber laser through the impulsive stimulated Raman scattering ͑ISRS͒ process. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] If the amplitude of the vibrations is large enough to break the weak links ͑presumably the hydrogen bonds͒ between the proteins, damage to the capsid of the virus occurs, leading to viral inactivation. However, we estimate that a single laser pulse from the USP laser used in our experiment probably can not generate large enough vibrational amplitude on the protein coat of a viral particle to break the weak hydrogen bonds ͑for example, if we use a Raman scattering cross section for a typical molecule and assume that the vibrational frequency of 1 GHz, then the amplitude of the excitation is estimated to be of the order of 10 −1 Å͒; rather, multiple laser pulses are required. Qualitatively, this is how it might work with multiple laser pulses. Let us assume that the links between the proteins of a capsid can be simulated with springs of given spring constants. The first laser pulse interacting with the capsid excites a tiny amplitude of vibration on the capsid. Because of the polar nature of water surrounding the capsid, it effectively screens the hydrogen bonds and as a result it softens the spring constants: Therefore, when the subsequent second laser pulse interacts with the excited capsid, the amplitude of the vibration on the excited capsid will be a little bit larger than that excited by the first laser pulse. This same argument can be applied for hundreds, thousands, or millions times depending on the experimental conditions. Our preliminary results, which indicate that it takes some time to inactivate viral particles, seem to be consistent with this scenario.
The other possible mechanism is the indirect generation of vibrations on the capid of a virus through electronic absorption of the laser radiation. Under this scenario, photons are first absorbed by the viral particles through electronic excitations to the higher electronic states. These energetic electronic states relax toward the ground state by giving off energy to vibrational states on the capsid of the viral particles, damaging the capid, and leading to the inactivation.
The third likely mechanism is the generation of a shock wave by the USP laser. A USP laser has been known ͑see Ref. 23 and the references therin͒ to produce a shock wave when interacting with materials including biological molecules.
Note that the specific mechanism accounting for our experimental results of inactivating viral particles with USP lasers is not known at this time. More work is required to clarify the possible mechanisms described here.
Note that the reason why there exists a window in laser power density that allows the selective inactivation of viruses, as demonstrated in Table 1 , is not known at this moment. One likely reason is the difference in the structure. We know that the structure of the lipid membrane on the cell is significantly different from that of the capsid of a viral particle. This structural difference might play a role in the interpretation. Another likely reason is the size effects. Viral particles are typically much smaller than mammalian cells. For example, HIV is an enveloped virus with a capsid and is about 0.1 m in diameter; whereas the shape of a human red blood cell is like a donut, about 10 m in diameter and 2 m in thickness. The mouse dendritic cell is about 10 m in diameter. Since the viruses and cells are embedded in water, the water molecules play a crucial role in the damping of the vibrations excited by the laser. The relatively large size of either the human red blood cell or the mouse dendritic cell as compared with that of the viral particle means that there are more water molecules surrounding the red blood cells and dendritic cells than HIV; in other words, the damping associated with the coherent/ incoherent excitation created by the laser is less for HIV than for red blood cells or dendritic cells. As a result, the amplitude of vibrations created by a given laser power density can be much higher for HIV than for red blood cells or mouse dendritic cells. It is obvious that if the laser causes the nucleic acid to leave a virus, as was shown in the AFM images of laserirradiated TMV sample in Fig. 3͑d͒ , damage to the virus has been produced. However, TMV can also become inactivated even with its RNA intact due to damage to its protective capsid. Consequently, the assay result-a 55% load reduction by laser irradiation ͑which used the release of RNA as an indicator for inactivation of TMV͒ represents a lower bound value.
Our experiments show that the near-IR subpicosecond fiber laser can reduce about 80% of the viral load in HIV samples. This is not sufficient by clinical standards for therapeutic purposes. However, we notice that the relatively small viral load reduction observed in our experiments is actually a manifestation of the use of a magnetic stirrer as well as the limitation imposed on the duration of the laser-irradiation time. If a more efficient way were used to get the photons in the laser beam to interact with the viral particles, then more efficient inactivation of viruses would have been achieved.
Conclusion
We demonstrated that a near-IR subpicosecond fiber laser can be used to selectively inactivate viral particles ranging from nonpathogenic viruses such as M13 bacteriophage and TMV to pathogenic viruses such as HPV and HIV, while leaving sensitive materials like human Jurkat T cells, human red blood cells, and mouse dendritic cells unharmed. This photonic approach targets the global mechanical properties of the viral protein shell, making it relatively insensitive to the local genetic mutation in the target viruses. As a result, the approach can inactivate both the wild and mutated strains of viruses. This intriguing advantage is particularly important in the treatment of diseases involving rapidly mutating viral species such as HIV. This USP laser technology could be used for the disinfection of viral pathogens in blood products and for the treatment of blood-borne viral diseases in the clinic.
